Clinical trial
Evaluation of the Real-World Efficacy of Tenapanor and Its Effects on Intestinal Metabolism in Patients Undergoing Maintenance Hemodialysis
NCT07882017 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Real-World Efficacy of Tenapanor and Its Effects on Intestinal Metabolism in Patients Undergoing Maintenance Hemodialysis
- Lead sponsor
- Huashan Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 23, 2026
- Completion date
- December 15, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hyperphosphatemia, maintenance hemodialysis